Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

MR + US-guided targeted biopsy boosts prostate cancer detection

Multiparametric MR imaging before a transrectal ultrasound (US)-guided targeted biopsy improves detection of prostate cancer over the standard extended systematic biopsy, according to a study published in the August issue of Radiology.

NEJM’s colorful explanation of how radium-223 targets bone metastases

Last month, a study published in The New England Journal of Medicine (NEJM) demonstrated how radium-223 could reduce the risk of death in patients with castration-resistant prostate cancer by targeting bone metastases, a common complication.

Speier Introduces Bill to Curb Self-Referral of Imaging and Radiation Oncology

Representatives Jackie Speier (D-CA), Ways and Means Health Subcommittee Ranking Member Jim McDermott (D-WA) and Dina Titus (D-NV), recently introduced H.R. 2914, the Promoting Integrity in Medicare Act of 2013 (PIMA), in the House of Representatives.

Chocolate on the Brain: MRI study shows cocoa boosts cognitive function

For older people showing signs of cognitive impairment, doctors could one day prescribe a daily dose of chocolate. New research shows regular cocoa consumption in the elderly led to significantly better neuronal metabolic function and blood flow, and subsequently improved cognition, according to a study published August 7 in Neurology.

Combined RIT is promising for genetically mutated colorectal cancer

Radioimmunotherapy (RIT) has not been able to gain traction for a majority of solid tumor types, but new evidence could put Cu-64 labeled DOTA-cetuximab in line for difficult-to-treat colorectal tumors with specific genetic mutations, according to a study published July 19 in the Journal of Nuclear Medicine.

F-18 FLT bests other F-18 labeled agents for antiangiogenic therapy response

Angiogenesis is a hallmark of invasive cancer and antiangiogenesis therapies are gaining momentum, but some patients do not respond well. F-18 FLT may be the strongest contender out of three F-18 labeled PET agents used to evaluate early response to therapy, which aims to improve patient management and negate unnecessary treatments, according to research published August 1 in the Journal of Nuclear Medicine.

High-res MR enterography trumps the standard in Crohn’s work-up

High-resolution MR enterography has significantly higher diagnostic accuracy in the diagnosis of bowel ulceration, fistulae and abscesses in Crohn’s disease compared to standard MRI, according to a study published in the September issue of Clinical Radiology.

Researchers use nano ‘SWAT team’ to bolster radiotherapy

Preliminary results of a pair of studies involving nanoparticles in cancer treatment have shown promising results for boosting the power of radiation therapy while preserving healthy tissue near tumors, according to research presented at the 55th Annual Meeting of the American Association of Physicists in Medicine in Indianapolis.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.